Kalaris Therapeutics Inc
KLRS · NASDAQ
Filings37
Total reported value$112.0M
| Manager | Shares | Value | Change |
|---|---|---|---|
| Samsara BioCapital, LLC | 11.4M | $97.0M | 0.0% |
| TANG CAPITAL MANAGEMENT LLC | 418.2K | $3.5M | +12.1% |
| Siren, L.L.C. | 318.3K | $2.7M | +10.1% |
| Woodline Partners LP | 241.1K | $2.0M | +50.0% |
| VANGUARD GROUP INC | 203.1K | $1.7M | +26.5% |
| RENAISSANCE TECHNOLOGIES LLC | 112.8K | $955.0K | +12.4% |
| Redmile Group, LLC | 83K | $702.6K | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 64.6K | $546.7K | +37.7% |
| BlackRock, Inc. | 40.4K | $342.0K | +5.2% |
| Squarepoint Ops LLC | 40.2K | $340.3K | -89.0% |
| Belpointe Asset Management LLC | 40K | $338.8K | +50.0% |
| Fortis Capital Advisors, LLC | 40K | $338.8K | +50.0% |
| MILLENNIUM MANAGEMENT LLC | 24.9K | $211.1K | +687.0% |
| MORGAN STANLEY | 24.9K | $211.1K | +47.9% |
| STATE STREET CORP | 22.6K | $191.5K | +34.5% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 22.5K | $190.6K | +50.0% |
| GOLDMAN SACHS GROUP INC | 22.5K | $190.3K | +50.0% |
| RBF Capital, LLC | 17.4K | $147.3K | 0.0% |
| MARSHALL WACE, LLP | 14.1K | $119.6K | 0.0% |
| Johnson Financial Group, Inc. | 10K | $84.7K | +50.0% |
| FMR LLC | 7.8K | $66.1K | 0.0% |
| UBS Group AG | 5.3K | $44.5K | +17.8% |
| FEDERATED HERMES, INC. | 578 | $4.9K | -10.7% |
| Strengthening Families & Communities, LLC | 268 | $2.3K | +50.0% |
| BANK OF AMERICA CORP /DE/ | 217 | $1.8K | -34.8% |
| BNP PARIBAS ARBITRAGE, SNC | 141 | $1.2K | 0.0% |
| JPMORGAN CHASE & CO | 50 | $423.5 | 0.0% |
| Parallel Advisors, LLC | 49 | $415.0 | 0.0% |
| Farther Finance Advisors, LLC | 33 | $279.5 | 0.0% |
| SBI Securities Co., Ltd. | 8 | $67.8 | -33.3% |
| CITIGROUP INC | 1 | $8.5 | +50.0% |
| XTX Topco Ltd | 0 | $0.0 | +100.0% |
| Octagon Capital Advisors LP | 0 | $0.0 | +100.0% |
| Tower Research Capital LLC (TRC) | 0 | $0.0 | +100.0% |
| RAYMOND JAMES FINANCIAL INC | 0 | $0.0 | +100.0% |
| TWO SIGMA ADVISERS, LP | 0 | $0.0 | +100.0% |
| GILEAD SCIENCES, INC. | 0 | $0.0 | +100.0% |